All people encounter, inhale, and ingest fungi on a daily basis. Although only several hundred of the estimated five million species of fungi worldwide cause disease in humans, advances in medical technologies and the global AIDS pandemic have dramatically increased our susceptibility to fungal disease.
Tobias M. Hohl, MD, PhD
Research FocusPhysician-scientist Tobias Hohl studies the molecular pathogenesis of human fungal pathogens and how the immune system responds to them.
- MD, Weill Medical College of Cornell University
- PhD, Weill Graduate School of Medical Sciences of Cornell University
- Espinosa, V., Jhingran, A., Dutta, O., Kasahara, S., Donnelly, R., Du, P., Rosenfeld, J., Leiner, I., Chen, C. C., Ron, Y., Hohl, T. M.*, and A. Rivera*. Inflammatory monocytes orchestrate innate antifungal immunity in the lung. PloS Pathog. 10:e1003940, 2014.
- Ngo, L. Y., Kasahara, S., Kumasaka, D. K., Knoblaugh, S. E., Jhingran, A., and T. M. Hohl. Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis. J. Infect. Dis. 209:109-119, 2014.
- Burroughs Wellcome Fund New Investigator in the Pathogenesis of Infectious Diseases (2014)
- Fellow, Infectious Diseases Society of America (2012)
- Young Investigator Award, American Society of Microbiology (2009)